Table 1.
Average consumption of antibacterials for systemic use in the community and hospital sector in the European Union/ European Economic Area, in 2019 and 2020 (expressed as DDD per 1000 inhabitants per day (ECDC 2020)
| Antimicrobial compound | Community sector | Hospital sector | ||
|---|---|---|---|---|
| 2019 | 2020 | 2019 | 2020 | |
| Tetracyclines | 2.1 | 1.6 | 0.09 | 0.05 |
| β-Lactams (penicillins) | 8 | 6.5 | 0.65 | 0.48 |
| Other β-lactam antibacterials | 2 | 1.7 | 0.4 | 0.43 |
| Sulfonamides and trimethoprim | 0.6 | 0.5 | 0.07 | 0.07 |
| Macrolides, lincosamides and streptogramins | 2.8 | 2.4 | 0.16 | 0.17 |
| Quinolones | 1.3 | 1.2 | 0.17 | 0.16 |
| Other antibacterials | 1.1 | 1 | 0.17 | 0.16 |
| Other groups | 0.1 | 0.1 | 0.06 | 0.05 |
Other groups are amphenicols, aminoglycosides and combination of antibacterials